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Current role of imaging methods in the diagnosis of cystic solid pancreas neoplasms - part IIRev iew
Current role of imaging methods in the diagnosis of cystic solid
pancreas neoplasms - part II
Papel atual dos métodos de imagem no diagnóstico das neoplasias císticas e
sólidas do pâncreas – 2a parte
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A B S T R A C T
The authors address the value of endoscopic retrograde cholangiopancreatography, ultrasonography, computed tomography,
magnetic resonance imaging and endoscopic ultrasound for the diagnosis of cystic and solid neoplasias of the pancreas, demonstrating
that each of them is of great importance to undoubtedly increase the diagnostic accuracy of the biliopancreatic system diseases. The
best method for each of several tumors is then determined.
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hypoechoic areas in about 97% of cases, about 3% being
isoechoic in relation to the sorrounding parenchyma. The
lesion is heterogeneous, with imprecise limits.
Pancreatic adenocarcinoma is usually seen at CT
as a focal,   poorly defined, heterogeneous and
hypoattenuated area that enhances less than the adjacent
normal pancreatic parenchyma. The sensitivity of CT in
detecting it as a hypoattenuated injury is directly related to
the technique applied, requiring thin-cut images (3-5mm)
obtained during rapid administration of iodinated contrast,
so that small tumors can be identified. Helical CT scanners
are recommended because they allow studies on arterial
and portal phases of the administration of intravenous
contrast medium and do not suffer interference from
respiratory movements. MRI with fat suppression, on its
turn, tends to significantly improve the sensitivity of the
diagnosis of tumors of the pancreas (Figure 11).
EE is the technique of choice for suspected focal
lesions in the pancreas. EE-FNA allows discarding the
diagnosis of tumor of the pancreas with a sensitivity of 85-
95% and specificity of around 100% for the diagnosis of
malignant tumors when performed by an experienced
physician24. However, it displays a lower negative predictive
value (between 20 and 50%) for the diagnosis of
malignancy and therefore a negative biopsy does not rule
out the existence of cancer24 (Figure 12).
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SOLID NEOPLASIAS
Ductal adenocarcinoma
This tumor is the most commonly found. It
appears at US and EE as a focal, usually hypoechoic,
rounded lesion, with irregular or undefined borders. The
smaller the size, the easier its identification due to its greater
clarity in relation to the adjacent parenchyma, and it does
not escape the field of view of the device22. The differential
diagnosis between pancreatitis and a focus of a malignant
tumor of the pancreas is difficult; however, the EE has a
high negative predictive value for the diagnosis of pancreatic
cancer. The diagnosis of a tumor on chronic pancreatitis,
on its turn, remains a challenge for the examiner23. In any
case, the cytology obtained by EE-FNA may provide
definitive information for the differential diagnosis.
Sonographic findings associated with pancreatic
carcinoma have been described. These findings can be
grouped into two categories: intra and extrapancreatic. The
intrapancreatic include: the emergence of the primary tu-
mor and its relationship with the MPD. The extrapancreatic
would be: biliary obstruction, liver metastases, regional
lymph node involvement, ascites, splenomegaly, invasion
of the spleen and the presence of collateral circulation with
thrombosis of portal vessels. The primary tumor displays a
localized alteration of the pancreas echotexture, with
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EE is considered the best technique for the diagnosis
of pancreatic tumors less than 3cm in diameter, which are the
best candidates for resection. Its sensitivity is superior to US,
CT and MRI and equal to the ERCP, but without its invasive
nature25. In addition, EE is widely used for tumor staging, with
excellent results, especially in lesions smaller than 4 cm, as it
can very accurately identify vascular invasion, both of the por-
tal trunk and the arterial axle, even in potentially resectable
patients identified by TC26. EE-FNA also enables the treatment
of uncontrollable pain caused by this type of tumor by injecting
alcohol for celiac plexus neurolysis27.
In the final line of the algorithm of unresectable
pancreatic head tumors (Figure 13) associated with biliary
or duodenal obstruction, ERCP is indicated, as it enables
the insertion of self-expandable metal prostheses in the
common bile duct or duodenum28 (Figure 14).
Functioning neuroendocrine neoplasia
There are several islet cell tumors. Some are
functioning and others not. They represent benign
adenomas and malignant pancreatic tumors and are usually
small. Functional tumors, as a result of their intense
hormonal activity, produce symptoms despite their small
size, which makes them more difficult to identify. The
nonfunctioning tumors are usually larger and easier to be
identified29. In general, neuroendocrine tumors are
homogeneous, solid and often hypoechoic, while some are
moderately echogenic. Calcifications and fluid spaces can
be seen in larger lesions. The tumors are spherical with
sharp edges, homogeneous and grow slow. The solid masses
are more likely to be functional, and the ones with necrotic
liquid component, less29.
The larger tumors are easily identified by both
CT and MRI. However, most of these tumors are small, so
it is essential to use a proper technique. Very thin cuts and
acquisition of early arterial phase are essential for
identification. MRI also offers the possibility to identify
hypointense nodules in T1 sequences, and hyperintense on
T2.
Insulinoma
Insulinoma is the most common functional
neuroendocrine tumor (60%). Its malignancy rate is 10%30.
Clinically, patients experience fasting hypoglycemia and
inappropriately elevated plasma insulin levels29 (Figure 15).
In 70% of patients there is a solitary adenoma, in 10%
Figure 11 - MRI: (A) sagital and (B) coronal sections, showing area of a tumor located in the cephalic portion of the pancreas.
Figure 12 - Echoendoscopy image of the case of the previous
figure. Note hypoechoic, heterogeneous nodular area,
with poorly defined borders, measuring 2x2cm. This
lesion invaded the splenomesenteric confluence.
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there are multiple adenomas and, in 10%, metastases.
The lesions may be tiny or reach 1500g. Nearly 90% of
insulinomas are less than 2cm and their small size makes
them poorly palpable during surgery. Their occur more
frequently in the body and tail of the pancreas, where the
concentration of Langerhans islets is larger31. EE-FNA is an
excellent method for the accurate diagnosis of these
nodules. Its sensitivity rate is around 80% for definite
diagnosis32,33 (Figura16).
Gastrinoma
Its occurrence reaches 18% of the neuroendocrine
tumors. The malignancy rate of gastrinomas varies from
25% to 60%. In patients with Zollinger-Ellison the lesions
are gastrinomas. They are associated with gastric
hypersecretion and peptic ulcer. Most of them are
Figure 15 - Patient with MEN I syndrome. MR image showing a
hypointense rounded nodule of about 2 cm. There
was doubt about the existence of splenosis.
Figure 14 - Radiologic image after the insertion of two prostheses,
one into the common bile duct and one into the
duodenum. The patient had advanced cancer of the
pancreas with invasion of adjacent structures
(uT4N1Mx).
Figure 13 - (A) After injection of contrast into the MPD, which is
dilated, and into the bile duct, which is also increased
in diameter, we noted a dual sign of stenosis, which
confirmed the finding of endoscopic ultrasound for
advanced pancreatic cancer. (B) Two 10 F plastic
prostheses were inserted.
pancreatic or peripancreatic, with 13% located in the
duodenum, and more than 60% of these lesions are
malignant34 (Figure 17).
Nonfunctioning neuroendocrine neoplasia
The nonfunctioning tumors represent 15% to
33% of all tumors in this category. They are easy to spot
because they reach a larger size before causing symptoms.
Their size range is generally 10 to 20 cm, usually not
detected until they reach a larger size. They are usually
solitary and cause abdominal pain (36%), jaundice (28%)
or a palpable mass. Most of these tumors are malignant
(60 to 92%). There are certain characteristics that seem
relevant to these tumors: large size, more than 10cm in
diameter, and hypoechogenicity, with more or less necrotic
areas29 (Figure 18).
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diagnosis of metastasis should be considered if the
lesions are found within the pancreas in patients with
known primary tumor. The incidence of pancreatic
metastasis affects 8.4% of patients with lung tumors,
19% with breast cancer and 37.5% with malignant
melanoma. Therefore, the following primary tumors
should be investigated when there is pancreatic
metastasis: melanoma, lung, breast and renal cancer,
hepatocellular carcinoma and sarcoma35.
Pancreatic lymphoma
Intra-abdominal lymphomas may also involve the
pancreas, producing granular hypoechoic masses. The su-
perior mesenteric vessels can be dislocated anteriorly, not
posteriorly, as seen in patients with primary pancreatic
tumors. Again, the definitive diagnosis is made by EE- FNA36
(Figure 21).
Figure 16 - Same case as the previous figure, submitted to EE-
FNA (A). The result of pathology revealed the presence
of a neuroendocrine tumor, confirmed by surgery (B).
Metastatic Pancreatic Disease
Direct invasion of surrounding organs by
tumors may also appear as primary pancreatic mass,
whose echotexture is hypoechoic. This may occur with
gastric, colonic, duodenal and biliary tumors. Since
the lesion cannot be distinguished from a primary car-
cinoma, the diagnosis should be made by EE-FNA. The
pancreas is rarely involved by metastatic disease from
other primary tumors, but when the invasion happens,
it usually does through direct invasion. Due to their
small size and paucity of clinical symptoms, pancreatic
metastases are not frequently diagnosed. In general,
they appear as homogeneous, solid lesions displaying
mass effect, with a more hypoechoic internal structure
(F igure 19),  or even as hypervascular nodules
occupying the pancreas of a patient with metastatic
clear cell carcinoma of the kidney (Figure 20). The
Figure 17 - Echoendoscopy images from two different gastrinoma
cases. In (A) the injury was in the back of the body of
the pancreas and in (B) the tumor was in the uncinate
process.
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Figure 18 - Patient with a nonfunctioning neuroendocrine tumor.
(A) CT scan showing a hypodense nodule located in
the cephalic portion of the pancreas, (B) endoscopic
ultrasound image confirmed the CT findings and the
biopsy revealed neuroendocrine tumor; In (C) image
of the surgical specimen.
Figure 19 - (A) pancreatic metastasis of a colon tumor operated
three years before; (B) metastasis from torso
melanoma identified and treated six months earlier.
Both were diagnosed by EE-FNA.
A
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Figure 20 - Two cases of pancreatic lymphoma diagnosed by EE-
FNA. (A) hypoechoic lesion, heterogeneous, imprecise
limits, the major was at the head of the pancreas, (B)
hypoechoic lesion, heterogeneous, imprecise limits of
5.6 x5, 0cm, located in the body of the pancrea.
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